EUVIMEDEUVIMED entdecken
Open Access

BRCA-associated protein1 (BAP1) immunohistochemical stain reliability in postbrachytherapy uveal melanoma enucleation specimens

Maya Eiger-Moscovich, Carol L Shields, Ralph C Eagle, Tatyana Milman

Indian Journal of Ophthalmology · 2024

DOI: 10.4103/ijo.ijo_648_23 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Indian Journal of Ophthalmology, 2024. Verfasst von Maya Eiger-Moscovich und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Wills Eye Hospital, Sidney Kimmel Medical College of Thomas Jefferson University, Philadelphia, PA, USA. Hauptthemen laut MEDLINE: Melanoma, Uveal Neoplasms, Eye Enucleation, Brachytherapy. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

The BRCA-associated protein1 (BAP1) immunohistochemical (IHC) stain has emerged as a powerful and inexpensive prognostic tool in uveal melanoma (UM), correlating with UM genetics and outcome. The data on the reliability of BAP1 immunohistochemistry in previously irradiated UM is scant. We aim to assess BAP1 IHC in post-Iodine-125 plaque brachytherapy-treated UM-enucleated eyes.

Methods

In a case-control study, the medical records of all patients who underwent enucleation for UM at a major Ocular Oncology Service from December 1 st , 2007 to December 31 st , 2014 were reviewed. All cases with either chromosome 3 (ch3) status or sufficient follow-up (>5 years or metastasis) were selected. Nuclear BAP1 (nBAP1) immunoreactivity was interpreted as intact (positive in >90% of nuclei), lost (positive in

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelanomaUveal NeoplasmsEye EnucleationBrachytherapyImmunohistochemistryUbiquitin ThiolesteraseTumor Suppressor ProteinsHumansUveal MelanomaFemaleMiddle AgedMaleRetrospective StudiesCase-Control StudiesAgedReproducibility of ResultsBiomarkers, TumorFollow-Up StudiesAdultPrognosisAged, 80 and over

Substanzen

BAP1 protein, humanUbiquitin ThiolesteraseTumor Suppressor ProteinsBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Pathology, Wills Eye Hospital, Sidney Kimmel Medical College of Thomas Jefferson University, Philadelphia, PA, USA.
  • Department of Ophthalmology, Hadassah Medical Center, Jerusalem, Israel.
  • Ocular Oncology Service, Wills Eye Hospital, Sidney Kimmel Medical College of Thomas Jefferson University, Philadelphia, PA, USA.

Zitieren

APA

Eiger-Moscovich, M., Shields, C. L., Eagle, R. C., & Milman, T. (2024). BRCA-associated protein1 (BAP1) immunohistochemical stain reliability in postbrachytherapy uveal melanoma enucleation specimens. Indian Journal of Ophthalmology. https://doi.org/10.4103/ijo.ijo_648_23

Vancouver

Eiger-Moscovich M, Shields CL, Eagle RC, Milman T. BRCA-associated protein1 (BAP1) immunohistochemical stain reliability in postbrachytherapy uveal melanoma enucleation specimens. Indian Journal of Ophthalmology. 2024. doi:10.4103/ijo.ijo_648_23

BibTeX
@article{EigerMoscovich2024,
  author = {Eiger-Moscovich, Maya and Shields, Carol L and Eagle, Ralph C and Milman, Tatyana},
  title = {BRCA-associated protein1 (BAP1) immunohistochemical stain reliability in postbrachytherapy uveal melanoma enucleation specimens},
  journal = {Indian Journal of Ophthalmology},
  year = {2024},
  doi = {10.4103/ijo.ijo_648_23}
}
Kostenlos starten →